Clinical Trials
5 trialsNCT05804669 2026-06-04
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Crinetics Pharmaceuticals Inc.
Phase 1/2 Recruiting
NCT07296484 2026-05-12
CAPTAIN-T2D
Sparrow Pharmaceuticals
Phase 2 Recruiting
NCT07361874 2026-03-27
IMPACT-MACS
University of Texas Southwestern Medical Center
Phase NA Recruiting
NCT07247058 2026-03-05
Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
Johns Hopkins University
Phase 4 Recruiting
NCT07104812 2026-02-11
Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Mayo Clinic
Phase 2 Recruiting